From Participation to Understanding: Reframing Engagement in Clinical Trials

Participant engagement is increasingly recognized as a critical factor in clinical trial success, yet it is often addressed as a peripheral consideration rather than a core component of study design. Emerging research suggests that participant understanding, access to information, and perceived purpose within a trial are directly linked to compliance, retention, and data quality. This article examines findings from participant-centered research and explores how engagement—when embedded into trial workflows—can shift from a reactive function to a proactive and measurable driver of study outcomes.

Clinical trials are designed to control variability. Protocols standardize procedures, inclusion criteria define populations, and technologies capture structured data. Despite these controls, one of the most significant sources of variability remains largely unmanaged: participant behavior.

Dropout, non-compliance, and missing data are often treated as operational challenges rather than behavioral outcomes. However, these issues rarely occur in isolation. They are typically preceded by a gradual decline in participant engagement—manifesting as delayed task completion, missed visits, or reduced interaction with study requirements.

Understanding and addressing this behavioral dimension is essential. Without it, even the most well-designed trials remain vulnerable to disruption.

The traditional approach to engagement

Historically, participant engagement has been addressed through a combination of static educational materials, site interactions, and reminder-based interventions. Participants are typically provided with study information at the outset and expected to retain and apply it throughout the trial.

Digital tools, including electronic clinical outcome assessment (eCOA) platforms, have improved data capture but have largely focused on task execution. Their primary function has been to collect responses, not to support the participant’s understanding of the study context.

This separation between data collection and participant experience creates a structural gap. Participants are asked to perform complex, protocol-driven activities without continuous access to the information needed to perform them effectively.

Participant-centered research: What patients actually want

Recent research conducted across global participant populations provides a more nuanced view of engagement. In a survey of over 500 individuals representing a broad range of ages, health conditions, and prior clinical trial experience, participants were asked to identify factors that would sustain their interest in a study.

The findings were consistent and instructive. Nearly half of respondents (46%) identified a better understanding of the importance of their participation as the single most impactful factor in maintaining engagement.

Additional findings reinforce this pattern. Recognition and appreciation were selected by 39% of participants as important motivators, while reminders for visits and tasks were selected by 37%. These factors contribute to engagement, but they are secondary to understanding and context.

These findings align with broader industry data. Global patient perception studies indicate that 81% of individuals are interested in educational initiatives that help them better understand clinical research, while 60% report that trust in pharmaceutical companies would increase with clearer, plain-language communication about risks and benefits.

Qualitative research further supports these conclusions. Participants consistently express a desire for greater clarity regarding study expectations, visit requirements, and the broader purpose of the trial.

Taken together, these data suggest that engagement is not primarily a request for additional interaction. It is a request for improved clarity, accessibility, and transparency.

The limits of gamification and incentive-based models

Engagement strategies often borrow from consumer applications, incorporating elements such as badges, scoring systems, and rewards. While these features can generate short-term interaction, their effectiveness in sustaining long-term engagement in clinical trials appears limited.

User testing across multiple engagement concepts reveals that such features tend to produce mixed or polarized responses. Scoring systems, for example, may motivate some participants but discourage others, particularly when performance appears low. Similarly, milestone-based rewards are often perceived as superficial when not clearly connected to meaningful outcomes.

These findings suggest that engagement strategies rooted in external motivation may be less effective than those addressing intrinsic drivers such as understanding, purpose, and confidence.

Uncertainty as a driver of disengagement

One of the most consistent themes across participant feedback is the role of uncertainty. Participants report that a lack of clarity around upcoming visits, procedures, and expectations contributes to anxiety and hesitation.

This uncertainty introduces friction into the participant experience. When individuals are unsure how to prepare for a visit or what will be required of them, they are more likely to delay or avoid engagement altogether.

From a data perspective, this friction manifests as variability. Missed windows, incomplete assessments, and protocol deviations often originate from gaps in understanding rather than lack of willingness.

Addressing uncertainty, therefore, is not simply a matter of improving participant experience. It is a strategy for improving data consistency, compliance, and overall trial performance.

Engagement as a behavioral signal

When engagement is viewed through a behavioral lens, it becomes possible to identify patterns that precede more visible issues such as dropout or non-compliance.

Digital interaction data, including login frequency, timing of task completion, and engagement with study materials, can provide early indicators of declining participation. These signals often emerge before traditional metrics detect a problem.

A participant who initially completed tasks promptly but begins to delay may be exhibiting early signs of disengagement. Similarly, reduced interaction with educational content may indicate a lack of understanding or confidence.

By monitoring these patterns, study teams can shift from reactive intervention to proactive support, addressing risks before they impact study outcomes.

Embedding engagement into trial workflows

To be effective, engagement must be integrated into the systems participants already use. This requires a shift in how digital platforms are designed and deployed.

Rather than functioning solely as data collection tools, platforms such as eCOA can serve as central points of interaction, providing participants with continuous access to study information, visibility into visit schedules, contextual guidance, and self-service resources for common questions.

Embedding engagement within these workflows ensures that support is available at the point of need, reducing reliance on memory, external materials, or delayed site interactions.

Implications for study design and execution

These findings have several implications for clinical trial design and execution.

Participant understanding should be treated as a core component of protocol execution rather than a secondary consideration. Providing clear, accessible, and timely information can reduce variability and improve compliance.

Engagement should be measured continuously, as behavioral data provides meaningful insight into participant experience and can inform targeted interventions.

Flexibility is also essential. As protocols evolve, engagement strategies must adapt to reflect changes in study requirements and participant needs.

Finally, engagement should be viewed as a shared responsibility across sponsors, sites, and technology providers, each contributing to a more cohesive participant experience.

Conclusion: From engagement to data integrity

Participant engagement is often discussed in terms of experience, but its impact extends far beyond perception. It directly influences the quality, completeness, and reliability of clinical trial data.

Across both participant-centered research and broader industry data, a consistent theme emerges: engagement is not a request for novelty. It is a request for less friction. Participants are asking for clearer communication, better access to information, and a more navigable trial experience.

The evidence suggests that engagement is most effective when it is grounded in understanding. Participants who feel informed, prepared, and connected to the purpose of a study are more likely to remain engaged and compliant over time.

As clinical trials continue to evolve, integrating engagement into core workflows and leveraging behavioral insights will be essential. Doing so not only improves participant experience but also strengthens the scientific foundation of the trial itself.

Aubrey Verna, Senior Director, Product, eCOA, YPrime

Sources

• YPrime. UX Research – Engagement Study.
• YPrime. Engagement Survey Results.
• YPrime. Patient Personas and User Stories Research.
• CISCRP. Perceptions & Insights Study: Public and Patient Perceptions of Clinical Research.